Allspring Global Investments Holdings LLC Cuts Stake in Humana Inc. $HUM

Allspring Global Investments Holdings LLC lowered its stake in shares of Humana Inc. (NYSE:HUM) by 95.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,298 shares of the insurance provider’s stock after selling 537,145 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Humana were worth $5,007,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in HUM. Montag A & Associates Inc. increased its position in Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares in the last quarter. CoreCap Advisors LLC raised its holdings in shares of Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares during the period. Fideuram Asset Management Ireland dac acquired a new stake in Humana in the fourth quarter valued at approximately $27,000. Reflection Asset Management acquired a new position in shares of Humana during the fourth quarter worth $29,000. Finally, Global Assets Advisory LLC acquired a new stake in Humana during the 1st quarter valued at $38,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Performance

Shares of HUM opened at $388.56 on Friday. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88. The company’s fifty day moving average is $364.10 and its 200-day moving average is $265.01. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The firm has a market cap of $46.65 billion, a price-to-earnings ratio of 41.56, a price-to-earnings-growth ratio of 2.15 and a beta of 0.71.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. During the same quarter in the prior year, the firm posted $11.58 EPS. The firm’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts expect that Humana Inc. will post 9.46 EPS for the current fiscal year.

Analysts Set New Price Targets

HUM has been the subject of a number of analyst reports. UBS Group reissued a “neutral” rating on shares of Humana in a report on Monday, June 15th. Leerink Partners increased their price target on shares of Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a research report on Thursday, April 30th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $425.00 target price on shares of Humana in a research report on Wednesday, June 3rd. Truist Financial boosted their price objective on shares of Humana from $320.00 to $415.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. Finally, Evercore upped their target price on Humana from $250.00 to $370.00 in a report on Thursday, June 11th. Two analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, fifteen have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $327.17.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.